首页> 外文期刊>Journal of Investigative Medicine High Impact Case Reports >Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio
【24h】

Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio

机译:蛋白尿,低白蛋白血症和慢性淋巴细胞性白血病:罕见的三重奏。

获取原文
       

摘要

Chronic lymphocytic leukemia (CLL) is a chronic, progressive lymphoproliferative disorder characterized by a monoclonal population of functionally incompetent lymphocytes. Renal involvement is rare and poorly described. A 57-year-old male with no prior medical history was diagnosed with CLL and followed with a watch and wait approach. He was referred to our institution several months later due to concern for Richter’s transformation to diffuse large B-cell lymphoma. A positron emission tomography/computed tomography scan showed no evidence of diffuse large B-cell lymphoma; however, the patient was noted to have hypoalbuminemia, nephrotic range proteinuria, an acute left renal vein thrombus, and a right pulmonary embolus. A nephrotic syndrome workup including autoimmunity and infection was unremarkable, and a kidney biopsy was deferred due to concern for renal compromise in the setting of a renal vein thrombus. The patient was treated with 6 cycles of reduced-dose fludarabine, cyclophosphamide, and rituximab for a presumed CLL-associated nephrotic syndrome and anticoagulation for his venous thromboemboli. At 6-month follow-up, the patient achieved complete remission of his CLL with normalization of all cell lines and resolution of his nephrotic range proteinuria. Repeat computed tomography scans showed no evidence of recurrent venous thromboemboli. This case demonstrates a potential role of empiric chemotherapy in cases of CLL-associated nephrotic syndrome given its potentially life-threatening sequelae and response to treatment.
机译:慢性淋巴细胞性白血病(CLL)是一种慢性进行性淋巴细胞增生性疾病,其特征是功能上无能的淋巴细胞是单克隆的。肾脏受累少见且描述不清。一名没有既往病史的57岁男性被诊断为CLL,随后进行了观察和等待。由于担心里希特(Richter)向弥漫性大B细胞淋巴瘤的转化,他几个月后被转介到我们的机构。正电子发射断层扫描/计算机断层扫描未显示弥漫性大B细胞淋巴瘤的证据;然而,该患者被发现患有低白蛋白血症,肾病范围蛋白尿,急性左肾静脉血栓和右肺栓塞。包括自身免疫和感染在内的肾病综合症检查并不明显,并且由于担心肾静脉血栓形成中的肾脏损害而推迟了肾脏活检。该患者接受了6个疗程的减少剂量的氟达拉滨,环磷酰胺和利妥昔单抗治疗,以治疗可能与CLL相关的肾病综合征,并因静脉血栓栓塞进行了抗凝治疗。在6个月的随访中,患者通过所有细胞系的正常化和肾病范围蛋白尿的缓解,完全缓解了CLL。重复的计算机体层摄影扫描未发现复发性静脉血栓栓塞的迹象。鉴于其可能危及生命的后遗症和对治疗的反应,该病例证明了经验化学疗法在CLL相关性肾病综合征病例中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号